Elizabeth L. R. Donley, JD, MBA, MS
Andrew Ferrara
R. Andrew Morgan, R.Ph
The Board of Stemina Biomarker Discovery is comprised of industry leaders with the business acumen and good judgment to lead us forward.
Stemina’s neurological disorders business unit has developed a test to aid in the earlier diagnosis of autism spectrum disorder.